• 검색 결과가 없습니다.

참고문헌

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. The Lancet. 2005; 365(9468): 1415-1428.

2. Beltra′n-Sa′nchez H, Harhay MO, Harhay MM, McElligott S.

Prevalence and trends of metabolic syndrome in the adult U.S.

population, 1999–2010. J Am Coll Cardiol. 2013; 62(8): 697-703.

3. Kim JH, Tanabe K, Yokoyama N, Zempo H, Kuno S. Objectively measured light-intensity lifestyle activity and sedentary time are independently associated with metabolic syndrome: a cross-sectional study of Japanese adults. Int J Behav Nutr Phys Act. 2013; 10(30).

4. Lim S, Shin H, Song JH, Kwak SH, Kang SM, Won Yoon J, et al.

Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutriton Examination Survey for 1998-2007.

Diabetes Care. 2011; 34(6): 1323-1328.

5. Jo YT. Korean Social Trends 2015. Statistical Research Institute.

Daejeon, South Korea. 2015, p. 103-104.

6. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al.

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and metaanalysis of longitudinal studies. J Am Coll Cardiol. 2007; 49(4): 403-414.

7. Reaven GM, Laws A. Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia. 1994; 37(9):

948-952.

8. Choi CS. Pathogenesis of insulin resistance. Korean J Med. 2009; 77(2):

171-177.

9. Kim KM, Lim S, Choi SH, Kim JH, Shin CS, Park KS, et al.

Cardiometabolic implication of sarcopenia: The Korea National Health and Nutrition Examination Study (KNHANES) 2008–2010. IJC Metabolic

& Endocrine. 2014; 4: 63-69.

10. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;

127(5): 990-991.

11. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al; European Working Group on Sarcopenia in Older People.

Sarcopenia: European consensus on definition and diagnosis: Report of the european working group on sarcopenia in older people. Age Ageing.

2010; 39(4): 412-423.

12. Bae EJ. Age-specific influencing factors of sarcopenia in Korean adults - Using the data from the 4th and 5th(2008-2011) Korea National Health and Nutrition Examination Survey - [dissertation]. Pukyong National University ; Korea. 2016.

13. Wang C, Bai L. Sarcopenia in the elderly: Basic and clinical issues.

Geriatr Gerontol Int. 2012; 12(3): 388-396.

14. Hong S, Choi WH. Clinical and physiopathological mechanism of sarcopenia. Korean J Med 2012; 83(4): 444-454.

15. Aubertin-Leheudre M, Lord C, Goulet ED, Khalil A, Dionne IJ. Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women. Obesity (Silver Spring) 2006; 14(12): 2277-2283.

16. Eckardt K, Görgens SW, Raschke S, Eckel J. Myokines in insulin resistance and type 2 diabetes. Diabetologia. 2014; 57(6): 1087–1099.

17. Carey AL, Steinberg GR, Macaulay SL, Thomas WG, Holmes AG, Ramm G, et al. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes. 2006; 55(10): 2688–2697.

18. Kang SY, Lim GE, Kim YK, Kim HW, Lee K, Park TJ, et al.

Association between Sarcopenic Obesity and Metabolic Syndrome in Postmenopausal Women: A Cross-sectional Study Based on the Korean National Health and Nutritional Examination Surveys from 2008 to 2011.

J Bone Metab. 2017; 24(1): 9-14.

19. Park HJ. Sarcopenic obesity is associated with metabolic syndrome:

based on Korea National Health and Nutrition Examination Surveys [dissertation]. Korea University ; Korea, 2013.

20. Lee YH, Kim SU, Song KJ, Park JY, Kim DY, Ahn SH, et al.

Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease:

nationwide Surveys(KNHANES 2008-2011). Hepatology 2016; 63(3):

776-786.

21. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an

American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.. Circulation. 2005; 112(17): 2735-2752.

22. Oh SW. Obesity and metabolic syndrome in Korea. Diabetes Metab J.

2011; 35(6): 561-566.

23. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147(8): 755-763.

24. Ishii S, Tanaka T, Akishita M, Ouchi Y, Tuji T, Iijima K, Kashiwa study investigators. Metabolic Syndrome, Sarcopenia and Role of Sex and Age: Cross-Sectional Analysis of Kashiwa Cohort Study. PLoS one.

2014; 9(11):e112718.

25. Kim YS, Lee Y, Chung YS, Lee DJ, Joo NS, Hong D, et al.

Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the fourth Korean National Health and Nutritional Examination Surveys. J Gerontol A Biol Sci Med Sci. 2012; 67(10):

1107-1113.

26. Zhang H, Lin S, Gao T, Zhong F, Cai J, Sun Y, et al. Association between Sarcopenia and Metabolic Syndrome in Middle-Aged and Older Non-Obese Adults: A Systematic Review and Meta-Analysis. Nutrients.

2018; 10(3). pii: E364.

27. Scott D, Park MS, Kim TN, Ryu JY, Hong HC, Yoo HJ, et al.

Association of low muscle mass and the metabolic syndrome in caucasian and asian middle -asian and older adults. J Nutr Health Aging. 2016; 20(3): 248-255.

28. Roubenoff R. Sarcopenic obesity: does muscle loss cause fat gain?

Lessons from rheumatoid arthritis and osteoarthritis. Ann N Y Acad Sci. 2000; 904: 553–557.

29. Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F, et al. Sarcopenic obesity and inflammation in the InCHIANTI study.

J Appl Physiol. 2007; 102(3): 919-925.

30. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37(12): 1595-1607.

31. Petersen KF, Dufour S, Savage DB, Bliz S, Solomon G, Yonemitsu S, et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. PNAS. 2007; 104(31): 12587–12594.

32. Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med. 2012; 18(3):

363-374.

33. Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012; 148(5): 852–871.

34. Petersen KF, Shulman GI. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol. 2002; 90(5A): 11G–

18G.

35. Bouzakri K, Koistinen HA, Zierath JR. Molecular mechanisms of skeletal muscle insulin resistance in type 2 diabetes. Curr Diabetes Rev.

2005; 1(2): 167–174.

36. Walsh K. Adipokines, myokines and cardiovascular disease. Circ J.

2009; 73(1): 13-18.

37. Pedersen BK. Muscle-to-fat interaction: a two-way street? J Physiol.

2010; 588(Pt 1): 21.

38. Ferreira I, Snijder MB, Twisk JW, van Mechelen W, Kemper HC, Seidell JC, et al. Central fat mass versus peripheral fat and lean mass:

opposite(adverse versus favorable) associations with arterial stiffness?

The Amsterdam Growth and Health Longitudinal Study. J Clin Endocrinol Metab. 2004; 89(6): 2632-2639.

39. Figueroa A, Park SY, Seo DY, Sanchez-Gonzalez MA, Baek YH.

Combined resistance and endurance exercise training improves arterial stiffness, blood pressure, and muscle strength in postmenopausal women.

Menopause. 2011; 18(9): 980-984.

40. Kim JH. Relationship between sarcopenia and metabolic syndrome in korean young adults: the korea national health and nutrition examination survey (KNHANES) 2009-2010 [dissertation]. Hallym University; Korea.

2016.

41. Gallagher D1, Visser M, De Meersman RE, Sepúlveda D, Baumgartner RN, Pierson RN, et al. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol. 1997; 83(1): 229-239.

42. Lexell J, Henriksson-Larsén K, Winblad B, Sjöström M. Distribution of different fiber types in human skeletal muscles: effects of aging studied in whole muscle cross sections. Muscle Nerve. 1983; 6(8):

588-595.

관련 문서